Over two years of research, design, and development is finally culminating as Mermaid Medical Group introduces its new brand and visual identity.
Copenhagen, Denmark, October 18th, 2021
The Corporate Branding Project has been underway since September 2019. The new brand identity includes revised vision, mission, and values statements as well as a new logo, new colors, and a new website.
"Mermaid Medical Group has grown significantly since our beginning in 2007”, says Lars Vinther, CEO of Mermaid Medical Group. “It has been a great journey, and I am very proud of the entire team. This new brand identity reflects where we come from and also where we are headed – towards an aligned, global brand focusing on partnerships to provide healthcare professionals with the best solutions for saving and improving patient lives.”
The new brand identity will influence online and physical presence, requiring new materials to be designed and developed across all outputs. As it influences product design, Mermaid Medical Group will implement the changes during a transition period.
“As we implement the changes, our partners may see our old logo and design on a product or data sheet, while also seeing our new logo and design at exhibitions and online”, says Daniel Lennartz, Sales & Marketing Director at Mermaid Medical Group. “We will do our best to make the transition as smooth as possible, and we are certain that our partners can see the value that the new brand brings.”
About Mermaid Medical Group
Mermaid Medical Group is a privately owned company established in 2007 devoted to developing, manufacturing, and distributing medical devices to hospitals and end users across Europe, the U.S., and Asia. Mermaid Medical primarily works within solutions to diseases in the vascular system as well as other devices used in interventional radiology and strive to be the preferred partner for manufacturers as well as hospitals and healthcare professionals in order to help patients across the world. For more information, visit www.mermaidmedical.com.
Mermaid Medical Group announces new exclusive distribution deal on the COBRA-OS® device for REBOA procedures from Front Line Medical Technologies Inc.
Mermaid Medical is proud to announce the appointment of Marcus Kildegaard Nielsen as the new global Sales Director, effective September 1st, 2024. Over the past six years, Marcus has made significant contributions in sales and marketing, bringing the right skills, ambitions, and mindset to ensure we keep driving the business forward.
Mermaid Medical proudly welcomes Daniel Nilsson Lennartz as the new Business Development Director, effective September 1st, 2024. As one of the co-founders, Daniel brings invaluable insights and expertise that will continue to drive the company’s growth and long-term success.